Johnson and Johnson’s COVID-19 Vaccine Will be First to Hold Clinical Trial in the Philippines

In a media briefing by the Food and Drug Administration (FDA) on Monday, Director General Eric Domingo confirmed that the US-based company Janssen Pharmaceuticals, which is owned by Johnson and Johnson, passed their final regulatory review. With this, Janssen Pharmaceuticals will be the first COVID-19 vaccine maker to hold a clinical trial in the Philippines.

Daniel Schludi Unsplash COVID 19 VaccineImage: Daniel Schludi via

Some Filipino netizens have raised concerns regarding the efficacy and safety of the earlier rolled-out vaccines by Pfizer and Moderna. Although clinical trials are done across various age groups, gender, and race, a clinical trial done in the Philippines where thousands of Filipinos could participate would surely put Pinoys’ minds at ease.

FDA Director General Domingo said Janssen Pharmaceuticals COVID-19 vaccine will start clinical trial in the Philippines potentially after the New Year.

Aside from Janssen Pharmaceuticals, two vaccine manufacturers, Sinovac Biotech and Clover Biopharmaceutical, both from China, are also under review to conduct clinical trials for their COVID-19 vaccines here in the Philippines.

ALSO READ: LOOK: UK Starts COVID-19 Mass Vaccination Program

What do you think of this news? Share your thoughts in the comments.

Do you have a story for the Team? Email us at or send us a direct message at’s Facebook Page. Interact with the team and join the community at WIM Squad and join our Viber group to keep updated with the latest news.

Related Stories